.

ISSN 2063-5346
For urgent queries please contact : +918130348310

APPLICATION OF DOE IN DEVELOPING A VALIDATED RP-HPLC METHOD TO EVALUATE DAPAGLIFLOZIN AND METFORMIN IN COMBINED TABLET DOSAGE FORM

Main Article Content

Dr. V. S. Saravanan1*, Mr. N. Tamilselvan2, P. V. Hemalatha3, Mr. D. Vikneshwaran4, Mr. K. S. Dinesh 5
» doi: 10.48047/ecb/2023.12.si10.00189

Abstract

In the current investigation, a statistical experimental design was used to create an isocratic RP-HPLC method for the simultaneous quantification of dapagliflozin and metformin in bulk and tablet dosage form. Acetonitrile concentration, buffer pH, and flow rate were used as three independent design variables. To thoroughly analyse the effects of these independent elements and analyse the response surface technique, Central Composite Design (CCD) was utilised. Derringer's desirability function was used to simultaneously optimise these three replies. ACN: Menthol (40:40:20) %V/V (pH-2.6) as the mobile phase and a flow rate of 1.0ml/min were the ideal test conditions. In order to verify the optimised procedure's specificity, linearity, accuracy, and precision, it was verified in accordance with ICH requirements.

Article Details